Tekubeiri subcutaneous injection 30mg (Teclistamab), from Janssen Pharmaceutical (YJ code: 4291475A1023, standard: 30mg 3mL bottle), is a bispecific T-cell engager antibody. It is approved for adults with relapsed or refractory multiple myeloma by targeting BCMA on cancer cells and CD3 on T-cells.
Tekubeiri subcutaneous injection 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →